Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

How safe is safe: new human immunodeficiency virus Type 1 variants missed by nucleic acid testing.

Transfusion - 1 Oct 2013

Müller Benjamin, Nübling C Micha, Kress Julia, Roth W Kurt, De Zolt Silke, Pichl Lutz

Abstract excerpt

BACKGROUND: Nucleic acid amplification techniques (NAT) in routine blood donor screening considerably reduce the diagnostic window phase period. Nevertheless, several reports of false-negative NAT results were published. Here, four cases of human immunodeficiency virus Type 1 (HIV-1) RNA-positive blood donations that escaped detection by NAT screening are described. STUDY DESIGN AND METHODS: A total of 2.7...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Donors
Share to Diagnostic Errors
Share to False Negative Reactions

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Infections

Share to Mass Screening

Share to Nucleic Acid Amplification Techniques

Share to Serologic Tests

Source

Identifiers

PMID: 23782012
DOI: 10.1111/trf.12298

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

How safe is safe: new human immunodeficiency virus Type 1 variants missed by nucleic acid testing.PMID 23782012Read ↗

Risk Minimization Measures for Blood Screening HIV-1 Nucleic Acid Amplification Technique Assays in GermanySemantic proximity Read ↗

Blood screening nucleic acid amplification tests for human immunodeficiency virus Type 1 may require two different amplification targetsSemantic proximity Read ↗

Improvement of an ultrasensitive human immunodeficiency virus type 1 real-time reverse transcriptase-polymerase chain reaction targeting the long terminal repeat region.Semantic proximity Read ↗

First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in GermanySemantic proximity Read ↗

Screening of HIV infection: role of molecular and immunological assays.Semantic proximity Read ↗

Antiviral resistance testing.Semantic proximity Read ↗

Truegene HIV-1 genotyping kit approval.Semantic proximity Read ↗

Development of the 1st International Reference Panel for HIV-1 RNA genotypes for use in nucleic acid-based techniques.Semantic proximity Read ↗

Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification TestingSemantic proximity Read ↗

[Detection of the nucleic acids of hepatitis B and C viruses and human immunodeficiency virus for the biological screening of blood donations. Viral Hepatitis and Retrovirus Working Groups and Subgroup for Molecular Biology Applied to Transfusion Virology of the French Blood Transfusion Society].Semantic proximity Read ↗

Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseasesSemantic proximity Read ↗

A cluster of human immunodeficiency virus Type 1 recombinant form escaping detection by commercial genomic amplification assaysSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.